Education
About Us
Working with TipRanks
Follow Us
Suven Pharmaceuticals Ltd. (IN:SUVENPHAR)
:SUVENPHAR
SUVENPHAR Stock Chart & Stats
₹891.10
₹6.60(0.60%)
At close: 4:00 PM EST
₹891.10
₹6.60(0.60%)
Day’s Range― - ―
52-Week Range₹521.45 - ₹1,328.20
Previous CloseN/A
Volume97.13K
Average Volume (3M)114.62K
Market Cap
₹205.88B
Enterprise Value₹339.28B
Total Cash (Recent Filing)₹6.56B
Total Debt (Recent Filing)₹0.00
Price to Earnings (P/E)66.3
Beta0.67
Next Earnings
Feb 09, 2026EPS Estimate
3.49Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)1.92
Shares Outstanding382,567,140
10 Day Avg. Volume20,700
30 Day Avg. Volume114,624
Financial Highlights & Ratios
PEG Ratio-9.41
Price to Book (P/B)15.93
Price to Sales (P/S)22.57
P/FCF Ratio204.09
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)11.11
Revenue Forecast (FY)₹27.57B
Suven Pharmaceuticals Ltd. News
SUVENPHAR FAQ
What was Suven Pharmaceuticals Ltd.’s price range in the past 12 months?
Suven Pharmaceuticals Ltd. lowest stock price was ₹521.45 and its highest was ₹1328.20 in the past 12 months.
What is Suven Pharmaceuticals Ltd.’s market cap?
Suven Pharmaceuticals Ltd.’s market cap is ₹205.88B.
When is Suven Pharmaceuticals Ltd.’s upcoming earnings report date?
Suven Pharmaceuticals Ltd.’s upcoming earnings report date is Feb 09, 2026 which is in 53 days.
How were Suven Pharmaceuticals Ltd.’s earnings last quarter?
Suven Pharmaceuticals Ltd. released its earnings results on Nov 12, 2025. The company reported ₹1.92 earnings per share for the quarter, beating the consensus estimate of ₹1.55 by ₹0.37.
Is Suven Pharmaceuticals Ltd. overvalued?
According to Wall Street analysts Suven Pharmaceuticals Ltd.’s price is currently Overvalued.
Does Suven Pharmaceuticals Ltd. pay dividends?
Suven Pharmaceuticals Ltd. pays a Notavailable dividend of ₹5 which represents an annual dividend yield of N/A. See more information on Suven Pharmaceuticals Ltd. dividends here
What is Suven Pharmaceuticals Ltd.’s EPS estimate?
Suven Pharmaceuticals Ltd.’s EPS estimate is 3.49.
How many shares outstanding does Suven Pharmaceuticals Ltd. have?
Suven Pharmaceuticals Ltd. has 382,567,140 shares outstanding.
What happened to Suven Pharmaceuticals Ltd.’s price movement after its last earnings report?
Suven Pharmaceuticals Ltd. reported an EPS of ₹1.92 in its last earnings report, beating expectations of ₹1.55. Following the earnings report the stock price went down -0.253%.
Which hedge fund is a major shareholder of Suven Pharmaceuticals Ltd.?
Currently, no hedge funds are holding shares in IN:SUVENPHAR
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Suven Pharmaceuticals Ltd.
Suven Pharmaceuticals Ltd. (SUVENPHAR) is a leading Indian pharmaceutical company specializing in the development, manufacturing, and marketing of pharmaceutical products, primarily in the areas of central nervous system (CNS) disorders, biopharmaceuticals, and contract research services. The company is focused on innovative drug discovery and development, with a robust pipeline of products aimed at addressing unmet medical needs, particularly in neurology. Suven's core offerings include active pharmaceutical ingredients (APIs), formulations, and specialized services in contract manufacturing and research.
Technical Analysis
Ajanta Pharma Limited
―
Biocon Limited
―
Glenmark Pharmaceuticals Limited
―
IPCA Laboratories Limited
―
Laurus Labs Ltd.
―